FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
Meeting the Needs of Laboratory Learners
The CDC’s OneLab training initiative offers free courses, events, resources, and networking opportunities for clinical lab professionals
Electronic Prior Authorization Bill Reintroduced in Congress
For clinical labs, the proposed law could bring more consistency to test ordering
Medicaid Fraud: Enforcement Continues to Trend Down as Labs Drift Deeper into the Background
From - National Intelligence Report
Last month, the OIG published its annual summary of Medicaid Fraud Control Unit (MCFU) activity for FY 2017. Here is a summary of the key findings, trends and…
Industry Trends: Small Labs Relying on Antitrust Laws to Protect Their Market Position
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
New FDA Guidance Aims to Ease Approval for New NGS Tests—But It Probably Won’t Work
From - National Intelligence Report
Test makers have long complained about the FDA's unwillingness to embrace technology and diagnostics advances. But on April 13, the agency took steps to address…
Enforcement Trends: Feds Turn Up the Heat on False Billing of Nuclear Stress Tests
From - National Intelligence Report
While the federal enforcement community has made urine drug testing of opioid drug patients its number one target for lab-related…
Emerging Tests: Medicare to Cover Next Gen-Sequencing Tests for Advanced Cancer
From - National Intelligence Report
In the PAMA era, there are two salient trends in Medicare Part B lab reimbursements…
Case of the Month: $33.2 Million Alere Settlement Sends Warning Shot Across Bow of LDT & DX Device Makers
From - National Intelligence Report
One of the reasons Abbott Laboratories got cold feet about consummating the $5.3 billion Alere acquisition was concern over the legal proceedings against the…
Diagnostic danger in the lab: Time to reform how we process orders
Recent report examining 10,000 claims to understand the key drivers of medical malpractice suits found 52 percent involved lab-related errors.
Genetic Testing: Natera Settles Prenatal DNA Testing False Billing Claims for $11.4 Million
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Tech Wars: Guardant & Foundation Make Sweet Lemonade Out of False Advertising Lemons
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here